Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: AAPS J. 2020 Jun 2;22(4):82. doi: 10.1208/s12248-020-00457-w

Table II.

TDS Dimensions and Nicotine Transport and Partition Parameters (ANOVA Least Squares Mean ± SE, n = 4 Skin Donors, 3–4 Replicates Per Donor) Calculated from the Optimization Analyses of 0–24-h 32°C and 42°C In Vitro Permeation Data in Franz Diffusion Cells (Protocols 1 and 2)

Product Nicotine content mg/cm2 Thickness (cm) C0 (mg/mL) KSCpb Dscc × 1010
(cm2/s)
EAd
(kJ/mol)
Total Backing Reservoira Modelb Expe Sigma minusb 32°C 42°C
TDS-N1
(two-layer TDS)
5.86 0.027 0.006 0.015 384 ± 7 391 ± 7 381 ± 10 3.73 ± 0.17 20f 44g 65 ± 6
TDS-N2
(homogeneous
TDS)
1.72 0.030 0.006 0.021 108 ± 7 83 ± 2 115 ± 10 1.14 ± 0.04 8.1 ± 0.5 16.0 ± 0.6 58 ± 5
a

Drug reservoir thickness (hres) calculated from: total thickness – thickness of backing membrane – thickness of membrane inside TDS

b

Products significantly different, p < 0.001

c

Products significantly different, p < 0.05

d

Experimentally determined activation energy value for aqueous nicotine: 65.9 kJ/mol

e

Experimentally determined nicotine concentration in TDS (mean ± SEM), calculated as: (Nicotine content) / hres

f

Value is the modified optimization value, and thus, SEM is not applicable; other values used in this model were: Dadh = 4 × 10−8 cm2 /s; Dp (32°C) = 2.27 × 10−10 cm2 /s; Dp (42°C) = 6.1 × 10−10 cm2 /s; cadh = 10 mol/m3

g

Value calculated from the modified optimization value at 32°C using EA; SEM is not applicable